Vitamin D deficiency and toxicity in chronic kidney disease: In search of the therapeutic window

Pediatric Nephrology

Volumn 25, Issue 12, 2010, Pages 2413-2430

  Querfeld, Uwe ^b   Mak, Robert H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Cardiovascular disease; Chronic kidney disease; Vitamin D; Vitamin D receptor

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; COLECALCIFEROL; DOXERCALCIFEROL; PARICALCITOL; VITAMIN D;

CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DISEASE COURSE; DRUG EFFECT; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; INCIDENCE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; REVIEW; RICKETS; UREMIA; VITAMIN D DEFICIENCY; VITAMIN D INTOXICATION;

ADOLESCENT; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; HUMANS; KIDNEY DISEASES; NUTRITION POLICY; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 78449310224     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-010-1574-2     Document Type: Review

References (175)

1. A Prentice 2008 Vitamin D deficiency: a global perspective Nutr Rev 66 S153 S164 18844843 10.1111/j.1753-4887.2008.00100.x
2. MF Holick 2007 Vitamin D deficiency N Engl J Med 357 266 281 1:CAS:528:DC%2BD2sXotVejsbc%3D 17634462 10.1056/NEJMra070553
3. IH de Boer B Kestenbaum AB Shoben ED Michos MJ Sarnak DS Siscovick 2009 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification J Am Soc Nephrol 20 1805 1812 19443637 10.1681/ASN.2008111157 1:CAS:528:DC%2BD1MXhtVers7rL
4. JH Lee JH O'Keefe D Bell DD Hensrud MF Holick 2008 Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 52 1949 1956 1:CAS:528:DC%2BD1cXhsVKlsLzF 19055985 10.1016/j.jacc.2008. 08.050
5. M Wolf A Shah O Gutierrez E Ankers M Monroy H Tamez D Steele Y Chang CA Camargo Jr M Tonelli R Thadhani 2007 Vitamin D levels and early mortality among incident hemodialysis patients Kidney Int 72 1004 1013 1:CAS:528: DC%2BD2sXhtFagtr%2FM 17687259 10.1038/sj.ki.5002451
6. FN Ali LM Arguelles CB Langman HE Price 2009 Vitamin D deficiency in children with chronic kidney disease: uncovering an epidemic Pediatrics 123 791 796 19255004 10.1542/peds.2008-0634
7. RW Chesney AV Moorthy JA Eisman DK Jax RB Mazess HF DeLuca 1978 Increased growth after long-term oral 1alpha, 25-vitamin D3 in childhood renal osteodystrophy N Engl J Med 298 238 242 1:STN:280:DyaE1c%2FntFGqtQ%3D%3D 201843 10.1056/NEJM197802022980503
8. RH Mak JH Wong 1992 The vitamin D/parathyroid hormone axis in the pathogenesis of hypertension and insulin resistance in uremia Miner Electrolyte Metab 18 156 159 1:STN:280:DyaK3s7gtFSmsQ%3D%3D 1465050
9. RH Mak 1998 1, 25-Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia Kidney Int 53 1353 1357 1:CAS:528:DyaK1cXjtV2hs7w%3D 9573552 10.1046/j.1523-1755.1998.00865.x
10. U Querfeld 2004 The clinical significance of vascular calcification in young patients with end-stage renal disease Pediatr Nephrol 19 478 484 15015069 10.1007/s00467-004-1450-z
11. JG Haddad LY Matsuoka BW Hollis YZ Hu J Wortsman 1993 Human plasma transport of vitamin D after its endogenous synthesis J Clin Invest 91 2552 2555 1:CAS:528:DyaK3sXltFKit70%3D 8390483 10.1172/JCI116492
12. JB Cheng MA Levine NH Bell DJ Mangelsdorf DW Russell 2004 Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase Proc Natl Acad Sci USA 101 7711 7715 1:CAS:528:DC%2BD2cXktlOlurg%3D 15128933 10.1073/pnas.0402490101
13. BW Hollis 2008 Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs Am J Clin Nutr 88 507S 510S 1:CAS:528:DC%2BD1cXhtVSrsL3O 18689391
14. AJ Batchelor G Watson JE Compston 1982 Changes in plasma half-life and clearance of 3H-25-hydroxyvitamin D3 in patients with intestinal malabsorption Gut 23 1068 1071 1:STN:280:DyaL3s%2FotVOjsQ%3D%3D 7173717 10.1136/gut.23.12.1068
15. T Richart Y Li JA Staessen 2007 Renal versus extrarenal activation of vitamin D in relation to atherosclerosis, arterial stiffening, and hypertension Am J Hypertens 20 1007 1015 1:CAS:528:DC%2BD2sXpvF2qt70%3D 17765144 10.1016/j.amjhyper.2007.03.017
16. TE Willnow A Nykjaer 2002 Pathways for kidney-specific uptake of the steroid hormone 25-hydroxyvitamin D3 Curr Opin Lipidol 13 255 260 1:CAS:528:DC%2BD38XktlWjsbs%3D 12045394 10.1097/00041433-200206000-00004
17. G Jones 2008 Pharmacokinetics of vitamin D toxicity Am J Clin Nutr 88 582S 586S 1:CAS:528:DC%2BD1cXhtVSrsLrL 18689406
18. S Vargas R Bouillon H Van Baelen LG Raisz 1990 Effects of vitamin D-binding protein on bone resorption stimulated by 1, 25 dihydroxyvitamin D3 Calcif Tissue Int 47 164 168 1:CAS:528:DyaK3MXhvVSjtA%3D%3D 2224592 10.1007/BF02555982
19. CD Engelman TE Fingerlin CD Langefeld PJ Hicks SS Rich LE Wagenknecht DW Bowden JM Norris 2008 Genetic and environmental determinants of 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D levels in Hispanic and African Americans J Clin Endocrinol Metab 93 3381 3388 1:CAS:528:DC%2BD1cXhtFChurjO 18593774 10.1210/jc.2007-2702
20. G Jones 2007 Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions of 1alpha, 25-dihydroxyvitamin D(3) Semin Dial 20 316 324 17635821 10.1111/j.1525-139X.2007.00302.x
21. AW Norman 2008 From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health Am J Clin Nutr 88 491S 499S 1:CAS:528:DC%2BD1MXhvVygt7s%3D 18689389 10.3945/ajcn.2008.27049
22. J Barsony K Prufer 2002 Vitamin D receptor and retinoid X receptor interactions in motion Vitam Horm 65 345 376 1:CAS:528:DC%2BD3sXhtVWiu78%3D 12481554 10.1016/S0083-6729(02)65071-X
23. T Shimada H Hasegawa Y Yamazaki T Muto R Hino Y Takeuchi T Fujita K Nakahara S Fukumoto T Yamashita 2004 FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis J Bone Miner Res 19 429 435 1:CAS:528:DC%2BD2cXisFCrsbg%3D 15040831 10.1359/JBMR.0301264
24. GJ Atkins PH Anderson DM Findlay KJ Welldon C Vincent AC Zannettino PD O'Loughlin HA Morris 2007 Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha, 25-dihydroxyvitamin D3 Bone 40 1517 1528 1:CAS:528:DC%2BD2sXlsF2nur8%3D 17395559 10.1016/j.bone.2007.02.024
25. SJ Slater MB Kelly FJ Taddeo JD Larkin MD Yeager JA McLane C Ho CD Stubbs 1995 Direct activation of protein kinase C by 1 alpha, 25-dihydroxyvitamin D3 J Biol Chem 270 6639 6643 1:CAS:528:DyaK2MXks1yis7g%3D 7896803 10.1074/jbc.270.12.6639
26. JA Huhtakangas CJ Olivera JE Bishop LP Zanello AW Norman 2004 The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha, 25(OH)2-vitamin D3 in vivo and in vitro Mol Endocrinol 18 2660 2671 1:CAS:528:DC%2BD2cXpslKksrY%3D 15272054 10.1210/me.2004-0116
27. E Falkenstein HC Tillmann M Christ M Feuring M Wehling 2000 Multiple actions of steroid hormones-a focus on rapid, nongenomic effects Pharmacol Rev 52 513 556 1:CAS:528:DC%2BD3MXislWksw%3D%3D 11121509
28. D Zehnder R Bland MC Williams RW McNinch AJ Howie PM Stewart M Hewison 2001 Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase J Clin Endocrinol Metab 86 888 894 1:CAS:528:DC%2BD3MXht1Knurw%3D 11158062 10.1210/jc.86.2.888
29. E Gottfried M Rehli J Hahn E Holler R Andreesen M Kreutz 2006 Monocyte-derived cells express CYP27A1 and convert vitamin D3 into its active metabolite Biochem Biophys Res Commun 349 209 213 1:CAS:528:DC%2BD28XpsVKrtrk%3D 16930540 10.1016/j.bbrc.2006.08.034
30. M van Driel M Koedam CJ Buurman M Hewison H Chiba AG Uitterlinden HA Pols JP van Leeuwen 2006 Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells FASEB J 20 2417 2419 17023519 10.1096/fj.06-6374fje 1:CAS:528:DC%2BD28XhtF2nurjN
31. U Segersten P Correa M Hewison P Hellman H Dralle T Carling G Akerstrom G Westin 2002 25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands J Clin Endocrinol Metab 87 2967 2972 1:CAS:528:DC%2BD38XkvFCjs7Y%3D 12050281 10.1210/jc.87.6.2967
32. PT Liu S Stenger H Li L Wenzel BH Tan SR Krutzik MT Ochoa J Schauber K Wu C Meinken DL Kamen M Wagner R Bals A Steinmeyer U Zugel RL Gallo D Eisenberg M Hewison BW Hollis JS Adams BR Bloom RL Modlin 2006 Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response Science 311 1770 1773 1:CAS:528:DC%2BD28Xis1eqtbk%3D 16497887 10.1126/science.1123933
33. MF Holick 2006 Resurrection of vitamin D deficiency and rickets J Clin Invest 116 2062 2072 1:CAS:528:DC%2BD28XnvF2msbs%3D 16886050 10.1172/JCI29449
34. R Bouillon G Carmeliet L Verlinden E van Etten A Verstuyf HF Luderer L Lieben C Mathieu M Demay 2008 Vitamin D and human health: lessons from vitamin D receptor null mice Endocr Rev 29 726 776 1:CAS:528:DC%2BD1cXhtlWrurzK 18694980 10.1210/er.2008-0004
35. CL Wagner FR Greer 2008 Prevention of rickets and vitamin D deficiency in infants, children, and adolescents Pediatrics 122 1142 1152 18977996 10.1542/peds.2008-1862
36. MF Holick 2005 Vitamin D for health and in chronic kidney disease Semin Dial 18 266 275 16076348 10.1111/j.1525-139X.2005.18402.x
37. MC Chapuy P Preziosi M Maamer S Arnaud P Galan S Hercberg PJ Meunier 1997 Prevalence of vitamin D insufficiency in an adult normal population Osteoporos Int 7 439 443 1:STN:280:DyaK1c%2Fos1Kgug%3D%3D 9425501 10.1007/s001980050030
38. CM Gordon KC DePeter HA Feldman E Grace SJ Emans 2004 Prevalence of vitamin D deficiency among healthy adolescents Arch Pediatr Adolesc Med 158 531 537 15184215 10.1001/archpedi.158.6.531
39. AJ Rovner KO O'Brien 2008 Hypovitaminosis D among healthy children in the United States: a review of the current evidence Arch Pediatr Adolesc Med 162 513 519 18524740 10.1001/archpedi.162.6.513
40. B Hoppe HE Gnehm M Wopmann T Neuhaus U Willi E Leumann 1992 Vitamin D poisoning in infants: a preventable cause of hypercalciuria and nephrocalcinosis Schweiz Med Wochenschr 122 257 262 1:STN:280:DyaK387nvFKntw%3D%3D 1311865
41. KJ Martin EA Gonzalez 2001 Vitamin D analogues for the management of secondary hyperparathyroidism Am J Kidney Dis 38 S34 S40 1:CAS:528: DC%2BD3MXovVGgtL0%3D 11689385 10.1053/ajkd.2001.28109
42. CP Sanchez IB Salusky 1996 The renal bone diseases in children treated with dialysis Adv Ren Replace Ther 3 14 23 1:STN:280:DyaK283gsFGrsw%3D%3D 8620364
43. MC Andrade JT Carvalhaes AB Carvalho M Lazarretti-Castro C Brandao 2007 Bone mineral density and bone histomorphometry in children on long-term dialysis Pediatr Nephrol 22 1767 1772 17680276 10.1007/s00467-007-0546-7
44. AJ Brown E Slatopolsky 2007 Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease Nat Clin Pract Endocrinol Metab 3 134 144 1:CAS:528:DC%2BD2sXhvVWrsLY%3D 17237840 10.1038/ncpendmet0394
45. JM Frazao P Martins 2009 Adynamic bone disease: clinical and therapeutic implications Curr Opin Nephrol Hypertens 18 303 307 1:CAS:528: DC%2BD1MXnsFyhtr4%3D 19424062 10.1097/MNH.0b013e32832c4df0
46. ML Melamed P Muntner ED Michos J Uribarri C Weber J Sharma P Raggi 2008 Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004 Arterioscler Thromb Vasc Biol 28 1179 1185 1:CAS:528:DC%2BD1cXlsFOju7g%3D 18417640 10.1161/ATVBAHA.108.165886
47. DH Kim S Sabour UN Sagar S Adams DJ Whellan 2008 Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004) Am J Cardiol 102 1540 1544 1:CAS:528:DC%2BD1cXhsVWnu7vN 19026311 10.1016/j.amjcard.2008.06.067
48. TJ Wang MJ Pencina SL Booth PF Jacques E Ingelsson K Lanier EJ Benjamin RB D'Agostino M Wolf RS Vasan 2008 Vitamin D deficiency and risk of cardiovascular disease Circulation 117 503 511 1:CAS:528:DC%2BD1cXotlCrtQ%3D%3D 18180395 10.1161/CIRCULATIONAHA.107.706127
49. H Dobnig S Pilz H Scharnagl W Renner U Seelhorst B Wellnitz J Kinkeldei BO Boehm G Weihrauch W Maerz 2008 Independent association of low serum 25-hydroxyvitamin d and 1, 25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality Arch Intern Med 168 1340 1349 1:CAS:528: DC%2BD1cXosFGrsLw%3D 18574092 10.1001/archinte.168.12.1340
50. R Scragg R Jackson IM Holdaway T Lim R Beaglehole 1990 Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study Int J Epidemiol 19 559 563 1:STN:280: DyaK3M%2FosF2qtg%3D%3D 2262248 10.1093/ije/19.3.559
51. A Zittermann SS Schleithoff G Tenderich HK Berthold R Korfer P Stehle 2003 Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 41 105 112 1:CAS:528: DC%2BD3sXpsVKjsQ%3D%3D 12570952 10.1016/S0735-1097(02)02624-4
52. E Giovannucci Y Liu BW Hollis EB Rimm 2008 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study Arch Intern Med 168 1174 1180 1:CAS:528:DC%2BD1cXnvVSksrk%3D 18541825 10.1001/archinte.168.11.1174
53. SE Judd MS Nanes TR Ziegler PW Wilson V Tangpricha 2008 Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey Am J Clin Nutr 87 136 141 1:CAS:528:DC%2BD1cXmt1amsg%3D%3D 18175747
54. M Chonchol R Scragg 2007 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey Kidney Int 71 134 139 1:CAS:528:DC%2BD2sXivFOlsw%3D%3D 17082756 10.1038/sj.ki.5002002
55. E Liu JB Meigs AG Pittas NM McKeown CD Economos SL Booth PF Jacques 2009 Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults J Nutr 139 329 334 1:CAS:528: DC%2BD1MXht1WntLs%3D 19106328
56. KC Chiu A Chu VL Go MF Saad 2004 Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction Am J Clin Nutr 79 820 825 1:CAS:528:DC%2BD2cXjs1ygsb4%3D 15113720
57. S Patel T Farragher J Berry D Bunn A Silman D Symmons 2007 Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis Arthritis Rheum 56 2143 2149 1:CAS:528:DC%2BD2sXovFSgsbs%3D 17599737 10.1002/art.22722
58. D Martins M Wolf D Pan A Zadshir N Tareen R Thadhani A Felsenfeld B Levine R Mehrotra K Norris 2007 Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey Arch Intern Med 167 1159 1165 1:CAS:528:DC%2BD2sXnvFakur4%3D 17563024 10.1001/archinte.167.11.1159
59. SJ Parikh M Edelman GI Uwaifo RJ Freedman M Semega-Janneh J Reynolds JA Yanovski 2004 The relationship between obesity and serum 1, 25-dihydroxy vitamin D concentrations in healthy adults J Clin Endocrinol Metab 89 1196 1199 1:CAS:528:DC%2BD2cXisVWrurY%3D 15001609 10.1210/jc.2003-031398
60. ES Ford UA Ajani LC McGuire S Liu 2005 Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults Diabetes Care 28 1228 1230 1:CAS:528:DC%2BD2MXksF2gsrk%3D 15855599 10.2337/diacare.28.5.1228
61. YC Li J Kong M Wei ZF Chen SQ Liu LP Cao 2002 1, 25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system J Clin Invest 110 229 238 1:CAS:528:DC%2BD38XlsVGlsbg%3D 12122115
62. K Aihara H Azuma M Akaike Y Ikeda M Yamashita T Sudo H Hayashi Y Yamada F Endoh M Fujimura T Yoshida H Yamaguchi S Hashizume M Kato K Yoshimura Y Yamamoto S Kato T Matsumoto 2004 Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice J Biol Chem 279 35798 35802 1:CAS:528:DC%2BD2cXmsl2htrg%3D 15205460 10.1074/jbc.M404865200
63. JR Wu-Wong M Nakane J Ma 2007 Vitamin D analogs modulate the expression of plasminogen activator inhibitor-1, thrombospondin-1 and thrombomodulin in human aortic smooth muscle cells J Vasc Res 44 11 18 1:CAS:528: DC%2BD2sXmt1Gmuw%3D%3D 17159355 10.1159/000097812
64. PM Timms N Mannan GA Hitman K Noonan PG Mills D Syndercombe-Court E Aganna CP Price BJ Boucher 2002 Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? Q J Med 95 787 796 1:STN:280:DC%2BD3s%2Fhs1emtA%3D%3D
65. U Querfeld MM Hoffmann G Klaus F Eifinger M Ackerschott D Michalk PA Kern 1999 Antagonistic effects of vitamin D and parathyroid hormone on lipoprotein lipase in cultured adipocytes J Am Soc Nephrol 10 2158 2164 1:CAS:528: DyaK1MXms1ylsrk%3D 10505692
66. KE Wong FL Szeto W Zhang H Ye J Kong Z Zhang XJ Sun YC Li 2009 Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins Am J Physiol Endocrinol Metab 296 E820 E828 1:CAS:528:DC%2BD1MXkvVyhtLs%3D 19176352 10.1152/ajpendo.90763.2008
67. MB Zemel X Sun 2008 Calcitriol and energy metabolism Nutr Rev 66 S139 S146 18844841 10.1111/j.1753-4887.2008.00099.x
68. X Sun MB Zemel 2007 Calcium and 1, 25-dihydroxyvitamin D3 regulation of adipokine expression Obesity (Silver Spring) 15 340 348 1:CAS:528: DC%2BD2sXosVamtb8%3D 10.1038/oby.2007.540
69. JR Wu-Wong J Tian D Goltzman 2004 Vitamin D analogs as therapeutic agents: a clinical study update Curr Opin Investig Drugs 5 320 326 1:CAS:528:DC%2BD2cXnt1SrtLY%3D 15083599
70. RU Simpson SH Hershey KA Nibbelink 2007 Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse J Steroid Biochem Mol Biol 103 521 524 1:CAS:528:DC%2BD2sXjt1Wns7g%3D 17275289 10.1016/j.jsbmb.2006.12.098
71. DX Tishkoff KA Nibbelink KH Holmberg L Dandu RU Simpson 2008 Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility Endocrinology 149 558 564 1:CAS:528: DC%2BD1cXht1yqtr0%3D 17974622 10.1210/en.2007-0805
72. A Rahman S Hershey S Ahmed K Nibbelink RU Simpson 2007 Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice J Steroid Biochem Mol Biol 103 416 419 1:CAS:528:DC%2BD2sXjt1Wgu7o%3D 17275288 10.1016/j.jsbmb.2006.12.081
73. M Martinesi S Bruni M Stio C Treves 2006 1, 25-Dihydroxyvitamin D3 inhibits tumor necrosis factor-alpha-induced adhesion molecule expression in endothelial cells Cell Biol Int 30 365 375 1:CAS:528:DC%2BD28Xjs1KjtLY%3D 16549374 10.1016/j.cellbi.2006.01.004
74. MA Raymond A Desormeaux A Labelle M Soulez G Soulez Y Langelier AV Pshezhetsky MJ Hebert 2005 Endothelial stress induces the release of vitamin D-binding protein, a novel growth factor Biochem Biophys Res Commun 338 1374 1382 1:CAS:528:DC%2BD2MXht1egs7%2FN 16269129 10.1016/j.bbrc.2005.10.105
75. R Riachy B Vandewalle E Moerman S Belaich B Lukowiak V Gmyr G Muharram J Kerr Conte F Pattou 2006 1, 25-Dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the Fas receptor Apoptosis 11 151 159 1:CAS:528:DC%2BD28XhvVSrtbs%3D 16502254 10.1007/s10495-006-3558-z
76. E Hypponen E Laara A Reunanen MR Jarvelin SM Virtanen 2001 Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study Lancet 358 1500 1503 1:STN:280:DC%2BD3MnltFKqsA%3D%3D 11705562 10.1016/S0140-6736(01)06580-1
77. MP Bjorkman AJ Sorva RS Tilvis 2008 Elevated serum parathyroid hormone predicts impaired survival prognosis in a general aged population Eur J Endocrinol 158 749 753 1:CAS:528:DC%2BD1cXmtlamsr8%3D 18426835 10.1530/EJE-07-0849
78. E Hagstrom P Hellman TE Larsson E Ingelsson L Berglund J Sundstrom H Melhus C Held L Lind K Michaelsson J Arnlov 2009 Plasma parathyroid hormone and the risk of cardiovascular mortality in the community Circulation 119 2765 2771 19451355 10.1161/CIRCULATIONAHA.108.808733 1:CAS:528:DC%2BD1MXmtlKhtbo%3D
79. CP Schmitt T Odenwald E Ritz 2006 Calcium, calcium regulatory hormones, and calcimimetics: impact on cardiovascular mortality J Am Soc Nephrol 17 S78 S80 1:CAS:528:DC%2BD28XjvFels7s%3D 16565253 10.1681/ASN.2005121338
80. S Bro K Olgaard 1997 Effects of excess PTH on nonclassical target organs Am J Kidney Dis 30 606 620 1:CAS:528:DyaK2sXntlSqu7o%3D 9370175 10.1016/S0272-6386(97)90484-4
81. A Covic P Kothawala M Bernal S Robbins A Chalian D Goldsmith 2009 Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease Nephrol Dial Transplant 24 1506 1523 19001560 10.1093/ndt/gfn613
82. X Qin MA Corriere LM Matrisian RJ Guzman 2006 Matrix metalloproteinase inhibition attenuates aortic calcification Arterioscler Thromb Vasc Biol 26 1510 1516 1:CAS:528:DC%2BD28XmvFyjtb8%3D 16690876 10.1161/01.ATV.0000225807.76419.a7
83. N Niederhoffer YV Bobryshev I Lartaud-Idjouadiene P Giummelly J Atkinson 1997 Aortic calcification produced by vitamin D3 plus nicotine J Vasc Res 34 386 398 1:CAS:528:DyaK2sXmslalsrw%3D 9349732 10.1159/000159247
84. RA Pierce ME Kolodziej WC Parks 1992 1, 25-Dihydroxyvitamin D3 represses tropoelastin expression by a posttranscriptional mechanism J Biol Chem 267 11593 11599 1:CAS:528:DyaK38XltVGjurc%3D 1597486
85. A Hinek MD Botney RP Mecham WC Parks 1991 Inhibition of tropoelastin expression by 1, 25-dihydroxyvitamin D3 Connect Tissue Res 26 155 166 1:STN:280:DyaK387hvF2ltg%3D%3D 1769236 10.3109/03008209109152434
86. S DeLuca D Sitara K Kang R Marsell K Jonsson T Taguchi RG Erben MS Razzaque B Lanske 2008 Amelioration of the premature ageing-like features of Fgf-23 knockout mice by genetically restoring the systemic actions of FGF-23 J Pathol 216 345 355 1:CAS:528:DC%2BD1cXhsVaitbzL 18729070 10.1002/path.2409
87. D Medici MS Razzaque S Deluca TL Rector B Hou K Kang R Goetz M Mohammadi OM Kuro BR Olsen B Lanske 2008 FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis J Cell Biol 182 459 465 1:CAS:528:DC%2BD1cXpvFKlt74%3D 18678710 10.1083/jcb.200803024
88. ME Tarver-Carr NR Powe MS Eberhardt TA LaVeist RS Kington J Coresh FL Brancati 2002 Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors J Am Soc Nephrol 13 2363 2370 12191981 10.1097/01.ASN.0000026493.18542.6A
89. ML Melamed B Astor ED Michos TH Hostetter NR Powe P Muntner 2009 25-hydroxyvitamin D levels, race, and the progression of kidney disease J Am Soc Nephrol 20 2631 2639 1:CAS:528:DC%2BD1MXhs1Witb3O 19875805 10.1681/ASN. 2009030283
90. P Ravani F Malberti G Tripepi P Pecchini S Cutrupi P Pizzini F Mallamaci C Zoccali 2009 Vitamin D levels and patient outcome in chronic kidney disease Kidney Int 75 88 95 1:CAS:528:DC%2BD1cXhsFSmtLjK 18843258 10.1038/ki.2008.501
91. R Mehrotra DA Kermah IB Salusky MS Wolf RI Thadhani YW Chiu D Martins SG Adler KC Norris 2009 Chronic kidney disease, hypovitaminosis D, and mortality in the United States Kidney Int 76 977 983 1:CAS:528:DC%2BD1MXht1Knt7%2FJ 19657329 10.1038/ki.2009.288
92. S Mathew RJ Lund LR Chaudhary T Geurs KA Hruska 2008 Vitamin D receptor activators can protect against vascular calcification J Am Soc Nephrol 19 1509 1519 1:CAS:528:DC%2BD1cXhtVWltr3P 18448587 10.1681/ASN.2007080902
93. N Koleganova G Piecha E Ritz ML Gross 2009 Calcitriol ameliorates capillary deficit and fibrosis of the heart in subtotally nephrectomized rats Nephrol Dial Transplant 24 778 787 1:CAS:528:DC%2BD1MXisVSlsLc%3D 18829613 10.1093/ndt/gfn549
94. N Koleganova G Piecha E Ritz CP Schmitt ML Gross 2009 A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia Kidney Int 75 60 71 1:CAS:528:DC%2BD1cXhsFSmtLjL 19092814 10.1038/ki.2008.490
95. D Haffner B Hocher D Muller K Simon K Konig CM Richter B Eggert J Schwarz M Godes R Nissel U Querfeld 2005 Systemic cardiovascular disease in uremic rats induced by 1, 25(OH)2D3 J Hypertens 23 1067 1075 1:CAS:528:DC%2BD2MXjt1Kms7c%3D 15834294 10.1097/01.hjh.0000166849.72721.1c
96. A Bas I Lopez J Perez M Rodriguez E Aguilera-Tejero 2006 Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function J Bone Miner Res 21 484 490 1:CAS:528:DC%2BD28XisFGqu74%3D 16491297 10.1359/JBMR.051211
97. SC Verberckmoes V Persy GJ Behets E Neven A Hufkens H Zebger-Gong D Muller D Haffner U Querfeld S Bohic ME De Broe PC D'Haese 2007 Uremia-related vascular calcification: more than apatite deposition Kidney Int 71 298 303 1:CAS:528:DC%2BD2sXhsVersL0%3D 17149373 10.1038/sj.ki.5002028
98. E Slatopolsky M Cozzolino JL Finch 2002 Differential effects of 19-nor-1, 25-(OH)(2)D(2) and 1alpha-hydroxyvitamin D(2) on calcium and phosphorus in normal and uremic rats Kidney Int 62 1277 1284 1:CAS:528:DC%2BD38XotVSntbc%3D 12234297 10.1111/j.1523-1755.2002.kid573.x
99. M Mizobuchi JL Finch DR Martin E Slatopolsky 2007 Differential effects of vitamin D receptor activators on vascular calcification in uremic rats Kidney Int 72 709 715 1:CAS:528:DC%2BD2sXpvFWlsb8%3D 17597697 10.1038/sj.ki.5002406
100. W Noonan K Koch M Nakane J Ma D Dixon A Bolin G Reinhart 2008 Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats Nephrol Dial Transplant 23 3824 3830 1:CAS:528:DC%2BD1cXhsVWlsr3E 18644798 10.1093/ndt/gfn375
101. JL Finch AJ Brown E Slatopolsky 1999 Differential effects of 1, 25-dihydroxy-vitamin D3 and 19-nor-1, 25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone J Am Soc Nephrol 10 980 985 1:CAS:528: DyaK1MXivF2hsbk%3D 10232683
102. SM Moe T Drueke 2008 Improving global outcomes in mineral and bone disorders Clin J Am Soc Nephrol 3 Suppl 3 S127 S130 18988697 10.2215/CJN.04331206
103. National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1-S201
104. Kidney Disease: Improving Global Outcomes (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int 113:S1-S130
105. K/DOQI NKF 2005 Clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease Am J Kidney Dis 46 S1 S121
106. MD Arenas F Alvarez-Ude MT Gil A Soriano JJ Egea I Millan ML Amoedo S Muray MA Carreton 2006 Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units Nephrol Dial Transplant 21 1663 1668 16464885 10.1093/ndt/gfl006
107. M Teng M Wolf MN Ofsthun JM Lazarus MA Hernan CA Camargo Jr R Thadhani 2005 Activated injectable vitamin D and hemodialysis survival: a historical cohort study J Am Soc Nephrol 16 1115 1125 1:CAS:528:DC%2BD2MXjsVWqt70%3D 15728786 10.1681/ASN.2004070573
108. M Teng M Wolf E Lowrie N Ofsthun JM Lazarus R Thadhani 2003 Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy N Engl J Med 349 446 456 1:CAS:528:DC%2BD3sXms1Ogsrg%3D 12890843 10.1056/NEJMoa022536
109. T Shoji K Shinohara E Kimoto M Emoto H Tahara H Koyama M Inaba S Fukumoto E Ishimura T Miki T Tabata Y Nishizawa 2004 Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population Nephrol Dial Transplant 19 179 184 1:CAS:528:DC%2BD3sXpvVeltbc%3D 14671054 10.1093/ndt/gfg513
110. AB Shoben KD Rudser IH de Boer B Young B Kestenbaum 2008 Association of oral calcitriol with improved survival in nondialyzed CKD J Am Soc Nephrol 19 1613 1619 1:CAS:528:DC%2BD1cXhtVWltrrI 18463168 10.1681/ASN.2007111164
111. M Naves-Diaz D Alvarez-Hernandez J Passlick-Deetjen A Guinsburg C Marelli D Rodriguez-Puyol JB Cannata-Andia 2008 Oral active vitamin D is associated with improved survival in hemodialysis patients Kidney Int 74 1070 1078 1:CAS:528:DC%2BD1cXhtFyqtbbN 18633342 10.1038/ki.2008.343
112. F Tentori JM Albert EW Young MJ Blayney BM Robinson RL Pisoni T Akiba RN Greenwood N Kimata NW Levin LM Piera R Saran RA Wolfe FK Port 2009 The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study Nephrol Dial Transplant 24 963 972 1:CAS:528:DC%2BD1MXisVSltL0%3D 19028748 10.1093/ndt/gfn592
113. SC Palmer DO McGregor P Macaskill JC Craig GJ Elder GF Strippoli 2007 Meta-analysis: vitamin D compounds in chronic kidney disease Ann Intern Med 147 840 853 18087055
114. AA Portale BE Booth HC Tsai RC Morris Jr 1982 Reduced plasma concentration of 1, 25-dihydroxyvitamin D in children with moderate renal insufficiency Kidney Int 21 627 632 1:CAS:528:DyaL38XitFGmsLw%3D 6896541 10.1038/ki.1982.70
115. O Gutierrez T Isakova E Rhee A Shah J Holmes G Collerone H Juppner M Wolf 2005 Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease J Am Soc Nephrol 16 2205 2215 1:CAS:528:DC%2BD2MXms1egsLs%3D 15917335 10.1681/ASN.2005010052
116. WT Chen K Yamaoka S Nakajima Y Tanaka T Yamamoto K Satomura S Okada Y Seino 1992 Evaluation of vitamin D-binding protein and vitamin D metabolite loss in children on continuous ambulatory peritoneal dialysis Bone Miner 17 389 398 1:STN:280:DyaK38zitlaqtw%3D%3D 1623332 10.1016/0169-6009(92)90788-F
117. S Gulati M Godbole U Singh K Gulati A Srivastava 2003 Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease? Am J Kidney Dis 41 1163 1169 12776267 10.1016/S0272-6386(03)00348-2
118. SK Mittal SC Dash SC Tiwari SK Agarwal S Saxena S Fishbane 1999 Bone histology in patients with nephrotic syndrome and normal renal function Kidney Int 55 1912 1919 1:STN:280:DyaK1M3ltV2mtg%3D%3D 10231454 10.1046/j.1523-1755. 1999.00413.x
119. J Auwerx L De Keyser R Bouillon P De Moor 1986 Decreased free 1, 25-dihydroxycholecalciferol index in patients with the nephrotic syndrome Nephron 42 231 235 1:STN:280:DyaL287hvV2ntA%3D%3D 3753749 10.1159/000183672
120. A Grymonprez W Proesmans M Van Dyck I Jans G Goos R Bouillon 1995 Vitamin D metabolites in childhood nephrotic syndrome Pediatr Nephrol 9 278 281 1:STN:280:DyaK2MzlvV2muw%3D%3D 7632510 10.1007/BF02254183
121. KG Koenig JS Lindberg JE Zerwekh PK Padalino HM Cushner JB Copley 1992 Free and total 1, 25-dihydroxyvitamin D levels in subjects with renal disease Kidney Int 41 161 165 1:STN:280:DyaK383nsl2rsw%3D%3D 1593853 10.1038/ki.1992.22
122. HJ van Hoof RG de Sevaux H van Baelen LM Swinkels C Klipping HA Ross CG Sweep 2001 Relationship between free and total 1, 25-dihydroxyvitamin D in conditions of modified binding Eur J Endocrinol 144 391 396 11275949 10.1530/eje.0.1440391
123. JC Chan MB Kodroff DM Landwehr 1981 Effects of 1, 25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure Pediatrics 68 559 571 1:STN:280:DyaL387gsFWrtg%3D%3D 6895662
124. IB Salusky WG Goodman BD Kuizon 2000 Implications of intermittent calcitriol therapy on growth and secondary hyperparathyroidism Pediatr Nephrol 14 641 645 1:STN:280:DC%2BD3M%2Fjt1ymuw%3D%3D 10912534 10.1007/s004670000352
125. J Silver J Russell LM Sherwood 1985 Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells Proc Natl Acad Sci USA 82 4270 4273 1:CAS:528: DyaL2MXksVymu7k%3D 3858880 10.1073/pnas.82.12.4270
126. CS Ritter HJ Armbrecht E Slatopolsky AJ Brown 2006 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells Kidney Int 70 654 659 1:CAS:528:DC%2BD28XnvVylt70%3D 16807549 10.1038/sj.ki.5000394
127. W Seeherunvong CL Abitbol J Chandar G Zilleruelo M Freundlich 2009 Vitamin D insufficiency and deficiency in children with early chronic kidney disease J Pediatr 154 e901 10.1016/j.jpeds.2008.12.028
128. S Menon RP Valentini G Hidalgo L Peschansky TK Mattoo 2008 Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease Pediatr Nephrol 23 1831 1836 18575896 10.1007/s00467-008-0842-x
129. V Belostotsky MZ Mughal JL Berry NJ Webb 2008 Vitamin D deficiency in children with renal disease Arch Dis Child 93 959 962 1:STN:280: DC%2BD1cnnsFOrsg%3D%3D 18463127 10.1136/adc.2007.134866
130. CB Langman ER Brooks 2006 Renal osteodystrophy in children: a systemic disease associated with cardiovascular manifestations Growth Horm IGF Res 16 Suppl A S79 S83 16624609 10.1016/j.ghir.2006.03.003
131. AS Dusso 2003 Vitamin D receptor: mechanisms for vitamin D resistance in renal failure Kidney Int Suppl 85 S6 S9 1:CAS:528:DC%2BD3sXkslyjsbc%3D 12753256 10.1046/j.1523-1755.63.s85.3.x
132. G Klaus A Watson A Edefonti M Fischbach K Ronnholm F Schaefer E Simkova
133. AG Clark A Oner G Ward C Turner SP Rigden GB Haycock C Chantler 1989 Safety and efficacy of calcium carbonate in children with chronic renal failure Nephrol Dial Transplant 4 539 544 1:STN:280:DyaK3c%2FhsFOktw%3D%3D 2507975
134. GA Block PS Klassen JM Lazarus N Ofsthun EG Lowrie GM Chertow 2004 Mineral metabolism, mortality, and morbidity in maintenance hemodialysis J Am Soc Nephrol 15 2208 2218 1:CAS:528:DC%2BD2cXlvVKmu7w%3D 15284307 10.1097/01.ASN.0000133041.27682.A2
135. S Briese S Wiesner JC Will A Lembcke B Opgen-Rhein R Nissel KD Wernecke J Andreae D Haffner U Querfeld 2006 Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy Nephrol Dial Transplant 21 1906 1914 1:CAS:528:DC%2BD28Xmt1Wkt7g%3D 16554325 10.1093/ndt/gfl098
136. M Litwin E Wuhl C Jourdan J Trelewicz A Niemirska K Fahr K Jobs R Grenda ZT Wawer P Rajszys J Troger O Mehls F Schaefer 2005 Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation J Am Soc Nephrol 16 1494 1500 15772249 10.1681/ASN.2004110932
137. MM Mitsnefes TR Kimball J Kartal SA Witt BJ Glascock PR Khoury SR Daniels 2005 Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism J Am Soc Nephrol 16 2796 2803 1:CAS:528:DC%2BD2MXhtFeisLvK 16049067 10.1681/ASN.2005030291
138. M Civilibal S Caliskan I Adaletli H Oflaz L Sever C Candan N Canpolat O Kasapcopur S Kuruoglu N Arisoy 2006 Coronary artery calcifications in children with end-stage renal disease Pediatr Nephrol 21 1426 1433 16821026 10.1007/s00467-006-0159-6
139. RC Shroff AE Donald MP Hiorns A Watson S Feather D Milford EA Ellins C Storry D Ridout J Deanfield L Rees 2007 Mineral metabolism and vascular damage in children on dialysis J Am Soc Nephrol 18 2996 3003 1:CAS:528: DC%2BD2sXhtlGgsbjE 17942964 10.1681/ASN.2006121397
140. R Shroff M Egerton M Bridel V Shah AE Donald TJ Cole MP Hiorns JE Deanfield L Rees 2008 A bimodal association of vitamin D levels and vascular disease in children on dialysis J Am Soc Nephrol 19 1239 1246 1:CAS:528:DC%2BD1cXns1yiu7o%3D 18337484 10.1681/ASN.2007090993
141. IB Salusky WG Goodman 2001 Adynamic renal osteodystrophy: is there a problem? J Am Soc Nephrol 12 1978 1985 1:STN:280:DC%2BD3MvnsFeqsA%3D%3D 11518793
142. BD Kuizon WG Goodman H Juppner I Boechat P Nelson B Gales IB Salusky 1998 Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD Kidney Int 53 205 211 1:CAS:528:DyaK1cXnsFCiuw%3D%3D 9453020 10.1046/j.1523-1755.1998.00724.x
143. GM London SJ Marchais AP Guerin P Boutouyrie F Metivier MC de Vernejoul 2008 Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD J Am Soc Nephrol 19 1827 1835 1:CAS:528: DC%2BD1cXhtFensrnJ 18480316 10.1681/ASN.2007050622
144. ML Frost R Grella SC Millasseau BY Jiang G Hampson I Fogelman PJ Chowienczyk 2008 Relationship of calcification of atherosclerotic plaque and arterial stiffness to bone mineral density and osteoprotegerin in postmenopausal women referred for osteoporosis screening Calcif Tissue Int 83 112 120 1:CAS:528:DC%2BD1cXhtVyisr%2FO 18612580 10.1007/s00223-008-9153-2
145. E Schulz K Arfai X Liu J Sayre V Gilsanz 2004 Aortic calcification and the risk of osteoporosis and fractures J Clin Endocrinol Metab 89 4246 4253 1:CAS:528:DC%2BD2cXnslWhs7c%3D 15356016 10.1210/jc.2003-030964
146. SM Moe NX Chen 2003 Calciphylaxis and vascular calcification: a continuum of extra-skeletal osteogenesis Pediatr Nephrol 18 969 975 15152617 10.1007/s00467-003-1276-0
147. CE Araya RS Fennell RE Neiberger VR Dharnidharka 2006 Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults Clin J Am Soc Nephrol 1 1161 1166 1:CAS:528:DC%2BD28Xht1GntbzL 17699342 10.2215/CJN.01520506
148. DS Milliner AR Zinsmeister E Lieberman B Landing 1990 Soft tissue calcification in pediatric patients with end-stage renal disease Kidney Int 38 931 936 1:STN:280:DyaK3M%2FpsVagtg%3D%3D 2266678 10.1038/ki.1990.293
149. HW Mawad BP Sawaya R Sarin HH Malluche 1999 Calcific uremic arteriolopathy in association with low turnover uremic bone disease Clin Nephrol 52 160 166 1:CAS:528:DyaK1MXmtlersrg%3D 10499311
150. LA Greenbaum N Benador SL Goldstein A Paredes JZ Melnick S Mattingly M Amdahl LA Williams IB Salusky 2007 Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis Am J Kidney Dis 49 814 823 1:CAS:528:DC%2BD2sXnsVSksL0%3D 17533024 10.1053/j.ajkd.2007.03.008
151. W Seeherunvong O Nwobi CL Abitbol J Chandar J Strauss G Zilleruelo 2006 Paricalcitol versus calcitriol treatment for hyperparathyroidism in pediatric hemodialysis patients Pediatr Nephrol 21 1434 1439 16900383 10.1007/s00467-006- 0204-5
152. AL Zisman W Ghantous P Schinleber L Roberts SM Sprague 2005 Inhibition of parathyroid hormone: a dose equivalency study of paricalcitol and doxercalciferol Am J Nephrol 25 591 595 1:CAS:528:DC%2BD2MXhtlahsr%2FK 16282676 10.1159/000089707
153. VC Dennis GL Albertson 2006 Doxercalciferol treatment of secondary hyperparathyroidism Ann Pharmacother 40 1955 1965 1:CAS:528:DC%2BD28XhtlSlt7fP 17062838 10.1345/aph.1G523
154. HE Joist SN Ahya K Giles K Norwood E Slatopolsky DW Coyne 2006 Differential effects of very high doses of doxercalciferol and paricalcitol on serum phosphorus in hemodialysis patients Clin Nephrol 65 335 341 1:CAS:528:DC%2BD28Xht1ehtrnK 16724654
155. M Mizobuchi D Towler E Slatopolsky 2009 Vascular calcification: the killer of patients with chronic kidney disease J Am Soc Nephrol 20 1453 1464 1:CAS:528:DC%2BD1MXovFehurs%3D 19478096 10.1681/ASN.2008070692
156. P Tuohimaa 2009 Vitamin D and aging J Steroid Biochem Mol Biol 114 78 84 1:CAS:528:DC%2BD1MXjvV2gsLo%3D 19444937 10.1016/j.jsbmb.2008.12.020
157. A Zittermann SS Schleithoff R Koerfer 2007 Vitamin D and vascular calcification Curr Opin Lipidol 18 41 46 1:CAS:528:DC%2BD2sXjvFOjsw%3D%3D 17218831 10.1097/MOL.0b013e328011c6fc
158. H Skjodt JA Gallagher JN Beresford M Couch JW Poser RG Russell 1985 Vitamin D metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitro J Endocrinol 105 391 396 1:CAS:528:DyaL2MXktlKmsLo%3D 3873510 10.1677/joe.0.1050391
159. JA Gallagher M Beneton L Harvey DE Lawson 1986 Response of rachitic rat bones to 1, 25-dihydroxyvitamin D3: biphasic effects on mineralization and lack of effect on bone resorption Endocrinology 119 1603 1609 1:CAS:528: DyaL28XlvVCrsbY%3D 3757903 10.1210/endo-119-4-1603
160. G Coen D Mantella M Manni A Balducci I Nofroni D Sardella P Ballanti E Bonucci 2005 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy Kidney Int 68 1840 1848 1:CAS:528: DC%2BD2MXhtFequ7vE 16164662 10.1111/j.1523-1755.2005.00603.x
161. K Terai H Nara K Takakura K Mizukami M Sanagi S Fukushima A Fujimori H Itoh M Okada 2009 Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels Br J Pharmacol 156 1267 1278 1:CAS:528:DC%2BD1MXlsVWmur0%3D 19302594 10.1111/j.1476-5381.2008.00108.x
162. S Waller R Shroff AJ Freemont L Rees 2008 Bone histomorphometry in children prior to commencing renal replacement therapy Pediatr Nephrol 23 1523 1529 18481109 10.1007/s00467-008-0838-6
163. L Rees 2008 What parathyroid hormone levels should we aim for in children with stage 5 chronic kidney disease; what is the evidence? Pediatr Nephrol 23 179 184 18043947 10.1007/s00467-007-0684-y
164. IB Salusky 2005 Are new vitamin D analogues in renal bone disease superior to calcitriol? Pediatr Nephrol 20 393 398 15690188 10.1007/s00467-004- 1788-2
165. O Mehls 1995 Do patients who are treated with calcitriol for renal osteodystrophy also need vitamin D3 therapy? Pediatr Nephrol 9 136 1:STN:280:DyaK2MzhsV2lsg%3D%3D 7794703 10.1007/BF00860725
166. JD Hernandez K Wesseling MI Boechat B Gales IB Salusky 2007 Osteomalacia in a hemodialysis patient receiving an active vitamin D sterol Nat Clin Pract Nephrol 3 227 232 17389892 10.1038/ncpneph0443
167. V Belostotsky Z Mughal NJ Webb 2009 A single high dose of ergocalciferol can be used to boost 25-hydroxyvitamin D levels in children with kidney disease Pediatr Nephrol 24 625 626 19048303 10.1007/s00467-008-1041-5
168. H Taskapan FF Ersoy PS Passadakis P Tam DE Memmos KP Katopodis C Ozener F Akcicek T Camsari K Ates R Ataman JG Vlachojannis NA Dombros C Utas T Akpolat S Bozfakioglu G Wu I Karayaylali T Arinsoy CP Stathakis M Yavuz DJ Tsakiris AD Dimitriades ME Yilmaz M Gultekin DG Oreopoulos 2006 Severe vitamin D deficiency in chronic renal failure patients on peritoneal dialysis Clin Nephrol 66 247 255 1:CAS:528:DC%2BD28XhtFOrtr3M 17063991
169. M Bak E Serdaroglu R Guclu 2006 Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome Pediatr Nephrol 21 350 354 16382319 10.1007/s00467-005-2118-z
170. MK Lehtonen-Veromaa TT Mottonen IO Nuotio KM Irjala AE Leino JS Viikari 2002 Vitamin D and attainment of peak bone mass among peripubertal Finnish girls: a 3-y prospective study Am J Clin Nutr 76 1446 1453 1:CAS:528: DC%2BD38Xpt1emtbY%3D 12450915
171. M Panczyk-Tomaszewska H Ziolkowska A Debinski M Sieniawska 2000 Vitamin D metabolite requirements in dialysed children receiving recombinant human growth hormone Nephrol Dial Transplant 15 375 378 1:CAS:528:DC%2BD3cXitVCjs7s%3D 10692523 10.1093/ndt/15.3.375
172. U Querfeld 2005 The therapeutic potential of novel phosphate binders Pediatr Nephrol 20 389 392 15650884 10.1007/s00467-004-1679-6
173. JB Wetmore LD Quarles 2009 Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift? Nat Clin Pract Nephrol 5 24 33 1:CAS:528:DC%2BD1cXhsFWju73F 18957950 10.1038/ncpneph0977
174. SL Furth SR Cole M Moxey-Mims F Kaskel R Mak G Schwartz C Wong A Munoz BA Warady 2006 Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study Clin J Am Soc Nephrol 1 1006 1015 17699320 10.2215/CJN.01941205
175. Querfeld U, Anarat A, Bayazit AK, Bakkaloglu AS, Bilginer Y, Caliskan S, Civilibal M, Doyon A, Duzova A, Kracht D, Litwin M, Melk A, Mir S, Sözeri B, Shroff R, Zeller R, Wühl E, Schaefer F; the 4C Study Group (2010) The Cardiovascular Comorbidity in Children with Chronic Kidney Disease Study (4C) Study: Objectives, Design and Methodology. Clin J Am Soc Nephrol (in press)